Bioequivalence of Simvastatin Tablets in Healthy Volunteers
Yang Yu
Abstract
Yang Yu
Abstract
Objective:To evaluate the bioequivalence of two kinds of Simvastatin tablets in healthy male volunteers.Methods:In a randomized crossover design,20 healthy male volunteers were given a single oral dose of 20 mg test or reference Simvastatin tablets.The concentrations of simvastatin in human plasma were determined by a HPLC-MS/MS method.Results:The main pharmacokinetic parameters of the test and reference Simvastatin tablets were as follows:c_(max) were(3.72±1.77) and(4.02±2.30) ng/ml,t_(max) were(1.5±0.8) and(1.3±0.5) h,AUC_(0~12 h) were(12.11±7.33) and(12.21±5.92) ng·h·ml~(-1),AUC_(0~∞) were(15.52 ± 9.79) and(15.48±9.65) ng·h·ml~(-1),and t_(1/2) were(6.5±4.2) and(5.8±4.7) h,respectively.The relative bioavailability of the test tablets was(103.4±32.6)%.There was no significant difference in c_(max),t_(max),AUC_(0~12 h),and AUC_(0~∞) between the two preparations.The 90% confidential interval of c_(max) and AUC were between 70%~143%,and 80%~125% respectively according to those of the reference tablets.Conclusion:The two preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the bioequivalence of two kinds of Simvastatin tablets in healthy male volunteers.Methods:In a randomized crossover design,20 healthy male volunteers were given a single oral dose of 20 mg test or reference Simvastatin tablets.The concentrations of simvastatin in human plasma were determined by a HPLC-MS/MS method.Results:The main pharmacokinetic parameters of the test and reference Simvastatin tablets were as follows:c_(max) were(3.72±1.77) and(4.02±2.30) ng/ml,t_(max) were(1.5±0.8) and(1.3±0.5) h,AUC_(0~12 h) were(12.11±7.33) and(12.21±5.92) ng·h·ml~(-1),AUC_(0~∞) were(15.52 ± 9.79) and(15.48±9.65) ng·h·ml~(-1),and t_(1/2) were(6.5±4.2) and(5.8±4.7) h,respectively.The relative bioavailability of the test tablets was(103.4±32.6)%.There was no significant difference in c_(max),t_(max),AUC_(0~12 h),and AUC_(0~∞) between the two preparations.The 90% confidential interval of c_(max) and AUC were between 70%~143%,and 80%~125% respectively according to those of the reference tablets.Conclusion:The two preparations were bioequivalent.
Key concepts: Bioequivalence, Simvastatin, Bioavailability, Pharmacokinetics, Crossover study, Medicine, Pharmacology, Chromatography